Company / Free Cash Flow per Share
Elicio Therapeutics, Inc. Free Cash Flow per Share History
FY2021-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$1.77
FY2022
5-year range
-$1.77 / -$1.50
FY2021-FY2022
Trend
-18.2%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-1.77 in FY2022.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, free cash flow per share decreased 18.2% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.36 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | -$1.77 | -18.2% |
| FY2021 | -$1.50 | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026